CoChat

Delayed Inhibition of VEGF Signaling after Stroke Attenuates Blood–Brain Barrier Breakdown and Improves Functional Recovery in a Comorbidity-Dependent Manner

Open access
Reeson, Patrick, Tennant, Kelly A., Gerrow, Kim, Wang, Josh, Weiser Novak, Sammy, Thompson, Kelsey, Lockhart, Krista-Linn, Holmes, Andrew, Nahirney, Patrick C., Brown, Craig E. · 2015 · The Journal of Neuroscience
Cited by 139

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Diabetes is a common comorbidity in stroke patients and a strong predictor of poor functional outcome. To provide a more mechanistic understanding of this clinically relevant problem, we focused on how diabetes affects blood–brain barrier (BBB) function after stroke. Because the BBB can be compromised for days after stroke and thus further exacerbate ischemic injury, manipulating its function presents a unique opportunity for enhancing stroke recovery long after the window for thrombolytics has passed. Using a mouse model of Type 1 diabetes, we discovered that ischemic stroke leads to an abnormal and persistent increase in vascular endothelial growth factor receptor 2 (VEGF-R2) expression in peri-infarct vascular networks. Correlating with this, BBB permeability was markedly increased in diabetic mice, which could not be prevented with insulin treatment after stroke. Imaging of capillary ultrastructure revealed that BBB permeability was associated with an increase in endothelial transcytosis rather than a loss of tight junctions. Pharmacological inhibition (initiated 2.5 d after stroke) or vascular-specific knockdown of VEGF-R2 after stroke attenuated BBB permeability, loss of synaptic structure in peri-infarct regions, and improved recovery of forepaw function. However, the beneficial effects of VEGF-R2 inhibition on stroke recovery were restricted to diabetic mice and appeared to worsen BBB permeability in nondiabetic mice. Collectively, these results suggest that aberrant VEGF signaling and BBB dysfunction after stroke plays a crucial role in limiting functional recovery in an experimental model of diabetes. Furthermore, our data highlight the need to develop more personalized stroke treatments for a heterogeneous clinical population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2810-14.2015

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 84

  1. 10.1007/s11940-011-0143-8 · DOI
  2. 10.1016/j.nbd.2003.12.016 · DOI · Paper page
  3. 10.1046/j.1471-4159.1994.62062404.x · DOI · Paper page
  4. 10.1161/01.STR.17.5.865 · DOI · Paper page
  5. 10.1161/STROKEAHA.109.551341 · DOI · Paper page
  6. 10.1016/j.neuron.2008.04.014 · DOI · Paper page
  7. 10.1371/journal.pone.0065663 · DOI
  8. 10.1097/01.WCB.0000078322.96027.78 · DOI · Paper page
  9. 10.1161/01.STR.24.1.111 · DOI · Paper page
  10. 10.1038/jcbfm.2014.18 · DOI · Paper page
  11. 10.1016/j.ejca.2006.09.015 · DOI · Paper page
  12. 10.1016/j.jneumeth.2005.10.011 · DOI
  13. 10.1016/S0896-6273(00)00084-2 · DOI · Paper page
  14. Feng, 1999, VEGF-induced permeability increase is mediated by caveolae, Invest Ophthalmol Vis Sci, 40, 157
  15. 10.1523/JNEUROSCI.5977-11.2012 · DOI · Paper page
  16. 10.1006/mvre.2001.2367 · DOI · Paper page
  17. Fong, 1999, SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types, Cancer Res, 59, 99
  18. 10.1002/gene.10117 · DOI · Paper page
  19. 10.1182/blood-2002-10-3023 · DOI · Paper page
  20. 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
  21. Gu, 2001, Vascular endothelial growth factor-A and -C protein up-regulation and early angiogenesis in a rat photothrombotic ring stroke model with spontaneous reperfusion, Acta Neuropathol, 102, 216, 10.1007/s004010100370 · DOI
  22. 10.1016/1056-8727(95)80013-5 · doi:10.1016/1056-8727(95)80013-5
  23. 10.2337/diab.46.5.847 · DOI · Paper page
  24. 10.1007/s00125-006-0485-z · DOI · Paper page
  25. 10.1016/j.freeradbiomed.2005.03.035 · DOI · Paper page
  26. 10.1016/j.stem.2009.01.006 · DOI · Paper page
  27. 10.1161/ATVBAHA.114.303090 · DOI · Paper page
  28. 10.1007/s100720200018 · DOI
  29. 10.1523/JNEUROSCI.4318-13.2013 · DOI · Paper page
  30. 10.1038/sj.bjc.6603813 · DOI · Paper page
  31. 10.1172/JCI111764 · DOI · Paper page
  32. 10.1371/journal.pone.0056419 · DOI · Paper page
  33. 10.1016/j.jns.2008.02.020 · DOI
  34. 10.1038/sj.jcbfm.9600382 · DOI
  35. 10.1007/BF00688633 · DOI · Paper page
  36. 10.1016/j.cell.2007.06.054 · DOI · Paper page
  37. 10.2337/db09-0902 · DOI · Paper page
  38. 10.1016/j.brainres.2013.10.021 · DOI
  39. Lossinsky, 2004, Structural pathways for macromolecular and cellular transport across the blood–brain barrier during inflammatory conditions, Histol Histopathol, 19, 535
  40. 10.1038/jcbfm.2010.210 · DOI
  41. Manoonkitiwongsa P Schultz R Lyden P (2011) in Therapeutic angiogenesis for vascular diseases, Safe and effective vascular endothelial cell growth factor (VEGF)-based therapeutic angiogenesis for ischemic stroke: insights from preclinical trials, ed Slevin M (Springer, Amsterdam), pp 169–212. · DOI
  42. Mendel, 2000, The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function, Clin Cancer Res, 6, 4848
  43. 10.1371/journal.pone.0044547 · DOI · Paper page
  44. Minchenko, 1994, Hypoxia regulatory elements of the human vascular endothelial growth-factor gene, Cell Mol Biol Res, 40, 35
  45. 10.1002/dvdy.20982 · DOI · Paper page
  46. 10.1523/JNEUROSCI.3908-10.2010 · DOI · Paper page
  47. 10.1111/ijs.12225 · DOI
  48. 10.1097/00005344-199701000-00002 · DOI · Paper page
  49. 10.1097/00005344-199503000-00008 · DOI · Paper page
  50. 10.2337/db11-1528 · DOI
  51. 10.1161/STROKEAHA.113.001660 · DOI
  52. 10.1096/fj.01-0253hyp · DOI · Paper page
  53. 10.1016/j.neuron.2011.07.013 · DOI · Paper page
  54. 10.1161/01.STR.29.10.2189 · DOI · Paper page
  55. 10.1371/journal.pone.0026612 · DOI · Paper page
  56. 10.1016/j.nbd.2008.08.005 · DOI · Paper page
  57. 10.1038/nmeth.2019 · DOI · Paper page
  58. 10.1212/WNL.49.1.113 · DOI · Paper page
  59. 10.1016/j.brainres.2004.11.054 · DOI · Paper page
  60. 10.3389/fnene.2014.00001 · DOI
  61. 10.1016/j.neuroscience.2006.01.016 · DOI
  62. 10.1161/STROKEAHA.109.564229 · DOI
  63. 10.1523/JNEUROSCI.1779-09.2009 · DOI · Paper page
  64. 10.1182/blood-2008-08-174508 · DOI · Paper page
  65. 10.1007/s00125-002-0782-0 · DOI
  66. 10.1038/sj.jcbfm.9600320 · DOI
  67. 10.1523/JNEUROSCI.5075-11.2012 · DOI
  68. 10.1523/JNEUROSCI.3513-13.2013 · DOI
  69. 10.1016/j.jneumeth.2009.04.009 · DOI · Paper page
  70. 10.1016/0006-291X(92)90483-2 · DOI · Paper page
  71. 10.1007/s001250051439 · DOI · Paper page
  72. 10.1007/BF00812155 · DOI
  73. 10.1016/j.jneumeth.2004.04.029 · DOI · Paper page
  74. 10.1007/BF01181571 · DOI
  75. 10.1016/S1056-8727(01)00212-4 · DOI
  76. 10.1126/scisignal.2004235 · DOI · Paper page
  77. 10.1161/STROKEAHA.110.586909 · DOI
  78. 10.1038/jcbfm.2010.119 · DOI · Paper page
  79. 10.1007/BF00691332 · DOI · Paper page
  80. 10.1002/ana.22538 · DOI · Paper page
  81. 10.1016/j.expneurol.2011.09.022 · DOI
  82. 10.1097/00004647-200204000-00002 · DOI · Paper page
  83. 10.1007/s12031-010-9487-x · DOI
  84. 10.1186/1472-6882-12-188 · DOI

Cited by

See all 139

Metadata

Authors
Reeson, P., Tennant, K. A., Gerrow, K., Wang, J., Weiser Novak, S., Thompson, K., Lockhart, K.-L., Holmes, A., Nahirney, P. C., & Brown, C. E.
Venue
The Journal of Neuroscience
Published
2015-04-01
Volume
35
Issue
13
Pages
5128-5143
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2083900005
Cited by
139
References
15
FWCI
8.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Delayed Inhibition of VEGF Signaling after Stroke Attenuates Blood–Brain Barrier Breakdown and Improves Functional Recovery in a Comorbidity-Dependent Manner. https://app.cochat.ai/papers/10.1523/jneurosci.2810-14.2015
The paper
Reeson, P., Tennant, K. A., Gerrow, K., Wang, J., Weiser Novak, S., Thompson, K., Lockhart, K.-L., Holmes, A., Nahirney, P. C., & Brown, C. E. (2015). Delayed Inhibition of VEGF Signaling after Stroke Attenuates Blood–Brain Barrier Breakdown and Improves Functional Recovery in a Comorbidity-Dependent Manner. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2810-14.2015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.